Business Context and Reporting Period
Company: Microchip Technology Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2004 (Second Quarter of Fiscal Year 2005)
Business Overview: Microchip designs, develops, manufactures, and markets semiconductor products, primarily embedded control products including microcontrollers, memory, and analog/interface devices. The company operates its own wafer fabrication facilities (Fab 2 and Fab 4) and assembly/test operations, with significant manufacturing presence in Thailand.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2004 |
Three Months Ended Sep 30, 2003 |
Six Months Ended Sep 30, 2004 |
Six Months Ended Sep 30, 2003 |
|---|---|---|---|---|
| Net Sales | $220,694 | $168,486 | $433,469 | $329,769 |
| Gross Profit | $126,377 | $91,194 | $247,836 | $146,715 |
| Gross Margin % | 57.3% | 54.1% | 57.2% | 44.5% |
| Operating Income | $75,051 | $47,594 | $124,905 | $58,106 |
| Net Income | $60,443 | $36,104 | $104,242 | $49,574 |
| Diluted EPS | $0.29 | $0.17 | $0.49 | $0.23 |
| Cash from Operations (6mo) | $184,965 (2004) vs $145,100 (2003) | |||
| Cash & Equivalents (Sep 30, 2004) | $75,225 | |||
| Short-term Investments (Sep 30, 2004) | $530,635 | |||
| Short-term Debt (Sep 30, 2004) | $42,275 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 31.0% year-over-year for the quarter and 31.4% for the six-month period, driven by increased demand across all product lines and unit volume growth of approximately 36% (quarter) and 41% (six months).
- Margin Expansion: Gross margins improved significantly to 57.3% (quarter) and 57.2% (six months) compared to 54.1% and 44.5% in the prior year. This improvement is largely due to the absence of $31.8 million in special charges related to the Fab 1 closure in the prior year, improved capacity utilization at Fab 2 (97%), and reduced start-up costs at Fab 3 and Fab 4.
- Special Charges: The company recorded a $21.1 million special charge in the quarter ended June 30, 2004 (included in the six-month 2004 data) related to a patent litigation settlement with Philips. No special charges were recorded in the current quarter (ended Sep 30, 2004).
- Operating Expenses: R&D expenses increased 10.3% and SG&A expenses increased 24.7% year-over-year for the quarter, primarily due to expanded technical resources, bonuses, and travel expenses.
Guidance, Outlook, and Risks
- Capital Expenditures: Management anticipates spending approximately $75 million over the next 12 months to maintain and selectively increase capacity, primarily for Fab 4 ramp-up and R&D equipment.
- Dividends: A quarterly dividend of $0.052 per share was declared on October 21, 2004, payable December 1, 2004. This represents an increase from the previous quarter's $0.046 per share.
- Stock Repurchases: The company has two active repurchase authorizations totaling 5 million shares. As of September 30, 2004, approximately 1.66 million shares remained available under the April 2004 authorization.
- Key Risks:
- Turns Orders: High reliance on "turns orders" (orders received and shipped in the same quarter) reduces visibility into future revenue.
- Competition & Pricing: Intense competition may lead to pricing pressure, particularly in Serial EEPROM and non-proprietary analog products.
- Manufacturing Capacity: Risks associated with ramping production at Fab 4, including yield issues and unanticipated costs.
- Accounting Changes: Implementation of FASB Statement 123R (effective June 2005) will require fair value accounting for stock options, negatively impacting reported earnings.
Investor Verification Checklist
- Philips Settlement Impact: Verify the cash outflow timing and confirm the $21.1 million charge was fully settled in the quarter ended September 30, 2004.
- Fab 4 Utilization: Monitor the ramp-up progress and yield rates at the new Fab 4 facility in Gresham, Oregon, as low utilization could pressure margins.
- Distributor Inventory: Review distributor inventory levels (currently ~2.5 months) to assess potential channel stuffing or future sell-through risks.
- Stock-Based Compensation: Analyze the pro-forma impact of SFAS 123R on future earnings, as the company currently expenses no compensation for stock options under APB 25.
- Short-term Debt: Confirm the purpose of the $42.3 million short-term debt (repurchase agreements collateralized by investments) and its impact on liquidity.